PA 2120 (Valproic Acid 250 mg)

Pill with imprint PA 2120 is White, Capsule-shape and has been identified as Valproic Acid 250 mg. It is supplied by Teva Pharmaceuticals USA.

Valproic acid is used in the treatment of bipolar disorder; mania; epilepsy; seizures; seizure prevention (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Valproic acid 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for PA 2120

Valproic Acid

Imprint:

PA 2120

Strength:

250 mg

Color:

White

Size:

19.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Fatty acid derivative anticonvulsants

Pregnancy Category:

D - Positive evidence of risk - When treating epilepsy
X - Not for use in pregnancy - When treating migraine

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Teva Pharmaceuticals USA

Inactive Ingredients:

corn oil
FD&C Blue No. 1
gelatin
glycerin
water
titanium dioxide
Note: Inactive ingredients may vary.

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer